Delhi-Court Orders Trial Over Massive Codeine Syrup Seizure Case
Delhi-A Delhi court has directed that a criminal trial proceed against a man accused of illegally possessing a massive quantity of codeine-based cough syrup, with investigators claiming the seized stock exceeded the commercial quantity limit defined under the Narcotic Drugs and Psychotropic Substances (NDPS) Act by a significant margin.
Court Finds Sufficient Grounds for Trial
A special court in Delhi has ruled that there is enough preliminary evidence to move forward with the prosecution of accused Vipin Chawla under the NDPS Act. Special Judge Jitendra Pratap Singh observed that the material submitted by investigators created a strong initial case and raised serious doubts regarding the accused’s involvement. Based on these findings, the court ordered that formal charges be framed, allowing the matter to proceed to trial.
The order, issued on July 30, stated that the evidence available at this stage was sufficient to justify further legal proceedings without making any final determination on guilt or innocence.
Defence Arguments Rejected by the Court
During the proceedings, the defence argued that Chawla was working only as a manager at Surya Pharma and was not personally responsible for the stock in question. It was also submitted that the cough syrup had been kept for return to the supplier after the government prohibited certain codeine-based formulations. The defence further maintained that the company held the necessary licences for its business activities.
However, the court did not accept these submissions at the present stage of the case. It observed that the quantity allegedly recovered was many times higher than the commercial quantity specified under the NDPS Act, making it a significant factor while deciding whether charges should be framed.
Forensic Material Strengthens Prosecution Case
The court also considered forensic findings presented during the investigation. According to the order, forensic examination connected the accused to the procurement process through signatures found on invoices that were under scrutiny. These documents were treated as an important part of the prosecution’s evidence while assessing the case at the charge-framing stage.
In addition, the court noted that the premises where the recovered medicines were allegedly stored did not possess the required licence. This observation was considered relevant while evaluating the circumstances surrounding the alleged possession of the drugs.
Details of the 2023 Police Operation
As outlined by the prosecution, officers from the Delhi Police Special Cell conducted a raid at a shop located in the Azadpur area in 2023. During the operation, investigators reportedly recovered 302 boxes containing a total of 36,238 bottles of codeine-based cough syrup, with each bottle having a capacity of 100 ml.
The prosecution has described the seizure as substantially exceeding the commercial quantity threshold prescribed under the NDPS Act. It argued that the scale of the recovery itself justified serious legal action under the provisions of the law.
Questions Raised Over Missing Inventory
Investigators further claimed that official records indicated a total supply of 48,818 bottles to the accused. However, documentation accounting for the remaining 12,580 bottles was allegedly unavailable during the investigation.
The prosecution has relied on this discrepancy as part of its case, suggesting that the missing records require further examination during the trial. The court has now decided that these issues, along with the evidence presented by both sides, should be fully examined during the course of judicial proceedings before arriving at any final conclusion.